Diabetic Neuropathy
Diabetic neuropathy is a type of nerve and blood vessel damage caused by high blood glucose levels in diabetes, resulting in symptoms such as numbness, tingling, pain, urinary problems, sexual dysfunction, and dizziness. It can involve various forms of nerve damage including distal symmetric polyneuropathy, cranial nerve palsies, mononeuropathies, and autonomic neuropathy.
Health Outcomes
- Beneficial Clinical Effects
- Changed Thermal Detection Threshold
- Changed Thermal Pain Threshold
- Changed Wind-Up Ratio
- Elevated Redox Status
- Enhanced Antioxidant Capabilities
- Enhanced Metabolite Levels
- Enhanced Radical Scavenging Ability
- Improved Antioxidant Enzyme Levels
- Improved Blood Glucose Levels
- Improved Corneal Nerve Length
- Improved Corneal Nerve Reflectivity
- Improved Corneal Nerve Width
- Improved Diabetic Foot Ulcer Healing
- Improved Metabolic Regulation
- Improved Microvascular Function
- Improved Neuropathy
- Improved Neuropathy Symptom Score
- Improved Pain Score
- Improved Peripheral Nervous System Disease
- Improved Rectal Sensation
- Improved Superoxide Dismutase Activity
- Improved Tactile Sensitivity
- Increase in Persistent Diseased Sites
- Increased Antioxidant Enzyme Levels
- Increased Antioxidant Potential
- Increased Burning Sensation
- Increased Mechanical Allodynia Distance
- Increased Oxidative Stress Tolerance
- Increased PPAR-γ Activity
- Increased Serum Glucose Levels
- Inhibited Absorption of Advanced Glycation End-products (AGEs)
- Modulated Metabolite Profile
- Modulated Nociceptive Signaling
- No Change in Overall Glucose Response
- Protection Against Oxidative Stress
- Reduced Advanced Glycation End Product Level
- Reduced Blood Glucose Elevation
- Reduced Burning Sensation
- Reduced Carboxymethyl Lysine
- Reduced Colonic Contraction Frequency
- Reduced Conditioned Pain Modulation
- Reduced Corneal Neuroma
- Reduced Days with Defecation Urgency
- Reduced Deoxysphinganine Level
- Reduced Diabetic Complications
- Reduced Diabetic Neuropathic Pain
- Reduced Diabetic Peripheral Neuropathy
- Reduced Dietary Advanced Glycation End Product Intake
- Reduced Gastric Emptying
- Reduced Gastric Emptying Time
- Reduced Gastroparesis Symptoms
- Reduced Glucotoxicity
- Reduced Glutathione Redox Ratio
- Reduced Glycation End Product Accumulation
- Reduced Gut Transit Time
- Reduced Incidence of Adverse Events
- Reduced LF/HF Ratio
- Reduced Leg Pain
- Reduced Muscle Cramp Duration
- Reduced Neurogenic Pain
- Reduced Neurological Symptoms
- Reduced Neuropathic Pain
- Reduced Neuropathy Total Symptom Score
- Reduced Pain Sensitivity
- Reduced Pain Severity
- Reduced Paresthesia Symptoms
- Reduced Peripheral Neuropathy
- Reduced Peripheral Neuropathy Grade
- Reduced Physiological Impairments
- Reduced Post-Void Residual Volume
- Reduced Serum Levels of CML
- Reduced Serum Malondialdehyde Levels
- Reduced Skin Sensitivity
- Reduced Soiling Rate
- Reduced Sour Taste Perception
- Reduced Thermal Pain Sensation
- Reduced Thermal Sensation
- Reduced Transit Time
- Reduced Urgency
- Reduction of Diabetes-Induced Organ Damage
- Stabilized Amino Acid Metabolism
- Stabilized Hemoglobin A1c Level